Skip to content

NIH scientists develop AI tool to predict how cancer patients will respond to immunotherapy

NIH scientists develop AI tool to predict how cancer patients will respond to immunotherapy
Tool uses routine clinical data to predict whether a cancer will respond to immune checkpoint inhibitors.

Table of Contents

NIH scientists have developed an AI tool that can predict how cancer patients will respond to immunotherapy. This tool uses routine clinical data, such as blood tests, to determine whether a patient's cancer will respond to immune checkpoint inhibitors. The study, published in Nature Cancer, was led by researchers at the National Cancer Institute's Center for Cancer Research and Memorial Sloan Kettering Cancer Center. The AI model, called LORIS, was able to accurately predict a patient's likelihood of responding to immunotherapy and how long they would live. The researchers have made the AI model publicly available and are calling for larger prospective studies to further evaluate its use in clinical settings. For more information, visit https://loris.ccr.cancer.gov.

Source

Latest